JOHN R MOORE Insider Trading $ARRY ARRAY BIOPHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN R MOORE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN R MOORE. JOHN R MOORE is VP, General Counsel in ARRAY BIOPHARMA INC ($ARRY).
JOHN R MOORE in ARRAY BIOPHARMA INC
Trading Symbol: ARRYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN R MOORE: VP, General Counsel
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 20 2006
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN R MOORE in ARRAY BIOPHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | M | 6.68 | 5,251 | 35,077 | 5,252 | |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | M | 3.75 | 14,277 | 53,539 | 4,759 | |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | M | 8.48 | 5,330 | 45,198 | 0 | |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Sell | S | 13.04 | 2,405 | 31,361 | 0 | 2.4 K to 0 (-100.00 %) |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Sell | S | 13.04 | 5,251 | 68,473 | 2,405 | 7.7 K to 2.4 K (-68.59 %) |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Buy | M | 6.68 | 5,251 | 35,077 | 7,656 | 2.4 K to 7.7 K (+218.34 %) |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Sell | S | 13.04 | 14,277 | 186,172 | 2,405 | 16.7 K to 2.4 K (-85.58 %) |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Buy | M | 3.75 | 14,277 | 53,539 | 16,682 | 2.4 K to 16.7 K (+593.64 %) |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Sell | S | 13.04 | 5,330 | 69,503 | 2,405 | 7.7 K to 2.4 K (-68.91 %) |
Nov 20 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Buy | M | 8.48 | 5,330 | 45,198 | 7,735 | 2.4 K to 7.7 K (+221.62 %) |
Sep 14 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | A | 8.37 | 20,000 | 167,400 | 20,000 | |
Feb 22 2006 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Sell | S | 9.38 | 4,456 | 41,797 | 2,252 | 6.7 K to 2.3 K (-66.43 %) |
Page: 1